UiPath Inc. (NYSE:PATH) Shares Acquired by Edgestream Partners L.P.

Edgestream Partners L.P. lifted its position in shares of UiPath Inc. (NYSE:PATH) by 73.2% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 403,098 shares of the healthcare company’s stock after buying an additional 170,426 shares during the period. Edgestream Partners L.P. owned approximately 0.07% of UiPath worth $5,111,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Intech Investment Management LLC increased its holdings in shares of UiPath by 3.1% during the 4th quarter. Intech Investment Management LLC now owns 14,324 shares of the healthcare company’s stock worth $356,000 after buying an additional 426 shares during the last quarter. Global Financial Private Client LLC boosted its position in shares of UiPath by 9.3% during the 1st quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock worth $144,000 after purchasing an additional 551 shares during the period. Principal Financial Group Inc. boosted its position in shares of UiPath by 1.7% during the 1st quarter. Principal Financial Group Inc. now owns 36,772 shares of the healthcare company’s stock worth $834,000 after purchasing an additional 622 shares during the period. GAMMA Investing LLC boosted its position in shares of UiPath by 40.2% during the 1st quarter. GAMMA Investing LLC now owns 2,204 shares of the healthcare company’s stock worth $50,000 after purchasing an additional 632 shares during the period. Finally, Lindbrook Capital LLC boosted its position in shares of UiPath by 46.0% during the 1st quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after purchasing an additional 639 shares during the period. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Trading Down 1.7 %

Shares of PATH opened at $12.27 on Wednesday. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The firm’s fifty day simple moving average is $12.12 and its 200-day simple moving average is $16.06. The firm has a market capitalization of $7.03 billion, a price-to-earnings ratio of -76.69 and a beta of 0.87.

UiPath (NYSE:PATH) last announced its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million for the quarter, compared to analyst estimates of $303.69 million. During the same period last year, the business earned ($0.09) EPS. The company’s revenue was up 10.0% on a year-over-year basis. On average, analysts predict that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on PATH. Evercore ISI increased their price objective on shares of UiPath from $13.00 to $16.00 and gave the stock an “in-line” rating in a research report on Friday, September 6th. Wells Fargo & Company increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the stock an “equal weight” rating in a research report on Friday, September 6th. William Blair cut shares of UiPath from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 30th. KeyCorp reissued a “sector weight” rating on shares of UiPath in a research report on Thursday, May 30th. Finally, Macquarie cut shares of UiPath from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $29.00 to $12.00 in a research report on Monday, June 3rd. Sixteen analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, UiPath presently has a consensus rating of “Hold” and a consensus price target of $17.71.

Insider Buying and Selling

In related news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction on Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at approximately $10,258,498.19. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 22.37% of the stock is owned by company insiders.

UiPath Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.